Dated disclosed rounds · latest 2022-06-01
Series B
MiroBio
Immunology (checkpoint agonists, autoimmune disease)
VerifiedSeries BOxford
- Companies House
- 11609215
- GLEIF LEI
- Not matched
- Latest evidence
- 2022-06-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:45:18.692Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
4 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Acquisition
$405M · 1 named investor
FundingSource fact Series B
$97M · 8 named investors
RegistryRegistry fact Company incorporated
MIROBIO LTD · company 11609215
Latest disclosed round
Series B
- Date
- 2022-06-01
- Amount
- USD 97m
- Sector
- Biotech & techbio
- Companies House
- 11609215
- ONS region
- South East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
7 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
Advent Life SciencesparticipantMedicxiparticipantMonographparticipantOrbiMedparticipantOxford Science EnterprisesparticipantSamsara BioCapitalparticipantSR Oneparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Advent Life Sciences | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Medicxi | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Monograph | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| OrbiMed | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Oxford Science Enterprises | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Samsara BioCapital | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| SR One | participant | 2022-06-01 | Biopharmadive ↗ · Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
2 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2022-08-04 | Acquisition | $405M | 1 additional source-listed name | Gilead ↗ · Gilead ↗ · Ac ↗ |
| 2022-06-01 | Series B | $97M | Oxford Science Enterprises · Samsara BioCapital · SR One · Medicxi · Advent Life Sciences · OrbiMed · 1 additional source-listed name · + 1 more linked | Biopharmadive ↗ · Ac ↗ |
Companies House status and filing snapshot
MIROBIO LTD
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2018-10-08
- Dissolved
- Not applicable
- Company number
- 11609215
Filing context
- Accounts category
- SMALL
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2026-03-25
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:45:18.692Z
72110Research and experimental development on biotechnology
CompanyBeacon statutory projection
MIROBIO LTD
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 11609215.
Latest retained status
active
- Checked
- 2026-08-25T03:45:18.692Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 1 dated CompanyBeacon membership
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.